A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma
Background & Aims: Sex-related differences in the immune pathogenesis of hepatocellular carcinoma (HCC), particularly related to oestrogen-dependent secretion of pro-tumourigenic cytokines, are well-known. Whether sex influences the efficacy and safety of immunotherapy is not known. Methods:...
Similar Items
-
PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
by: D'Alessio A, et al.
Published: (2021-08-01) -
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
by: Yue Linda Wu, et al.
Published: (2022-11-01) -
Problem of gender culture in contemporary academic discourse
by: Natalia Tokova, et al.
Published: (2018-03-01) -
Problem of gender culture in contemporary academic discourse
by: Natalia Tokova, et al.
Published: (2018-03-01) -
Review of the National Experience of Measuring Gender Inequality in Ukraine, 2009–2021. Part I. Government Practice of Gender Measurements
by: M. M. Skoryk
Published: (2022-03-01)